NVS - Morphosys ADRs gain after definitive merger ageement with Novartis disclosed
2024-02-07 09:52:29 ET
More on MorphoSys
- Novartis And MorphoSys Are A Perfect Match
- MorphoSys: Positive Pelabresib Data Finally Unlocking Upside
- MorphoSys: A Buying Opportunity Following Mixed Phase 3 Results In Myelofibrosis
- MorphoSys drops amid speculation Novartis could walk from deal (update)
- Incyte buys global rights for tafasitamab from MorphoSys